Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

blinatumomab 2Carboplatin 2venetoclax 1treosulfan 1flumatinib 1fludarabine phosphate 1anlotinib 1aflutinib 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Maintenance 1Interferon alpha-2 1Inotuzumab Ozogamicin 1Injections 1Immunotherapy 1Drug Therapy 1Docetaxel 1Decitabine 1Cytarabine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carmustine 1Busulfan 1Bortezomib 1Blood Specimen Collection 1Azacitidine 1Anti-Inflammatory Agents, Non-Steroidal 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm, Residual × Aminolevulinic Acid × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Unknown
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡